TLNRD1 is a CCM complex component and regulates endothelial barrier integrity.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 06 10 2023
revised: 08 04 2024
accepted: 23 05 2024
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 16 7 2024
Statut: ppublish

Résumé

We previously identified talin rod domain-containing protein 1 (TLNRD1) as a potent actin-bundling protein in vitro. Here, we report that TLNRD1 is expressed in the vasculature in vivo. Its depletion leads to vascular abnormalities in vivo and modulation of endothelial cell monolayer integrity in vitro. We demonstrate that TLNRD1 is a component of the cerebral cavernous malformations (CCM) complex through its direct interaction with CCM2, which is mediated by a hydrophobic C-terminal helix in CCM2 that attaches to a hydrophobic groove on the four-helix domain of TLNRD1. Disruption of this binding interface leads to CCM2 and TLNRD1 accumulation in the nucleus and actin fibers. Our findings indicate that CCM2 controls TLNRD1 localization to the cytoplasm and inhibits its actin-bundling activity and that the CCM2-TLNRD1 interaction impacts endothelial actin stress fiber and focal adhesion formation. Based on these results, we propose a new pathway by which the CCM complex modulates the actin cytoskeleton and vascular integrity.

Identifiants

pubmed: 39013281
pii: 276861
doi: 10.1083/jcb.202310030
pii:
doi:

Substances chimiques

CCM2 protein, human 0
TLN1 protein, human 0
Carrier Proteins 0
Actins 0
Talin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biocenter Finland
Organisme : Research Council of Finland
ID : 338537
Organisme : Sigrid Juselius Foundation
Organisme : Cancer Society of Finland
Organisme : Åbo Akademi University
Organisme : Academy of Finland
ID : 337530
Organisme : Finnish Cancer Institute
Organisme : Centre of Excellence
ID : # 346131
Organisme : Jane and Aatos Erkko Foundation
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S007245/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CRUK-A21671
Pays : United Kingdom

Informations de copyright

© 2024 Ball et al.

Auteurs

Neil J Ball (NJ)

School of Biosciences, University of Kent, Canterbury, UK.
Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Sujan Ghimire (S)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.

Gautier Follain (G)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Ada O Pajari (AO)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.

Diana Wurzinger (D)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.

Monika Vaitkevičiūtė (M)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.

Alana R Cowell (AR)

School of Biosciences, University of Kent, Canterbury, UK.

Bence Berki (B)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Johanna Ivaska (J)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Department of Life Technologies, University of Turku, Turku, Finland.
Western Finnish Cancer Center (FICAN West), University of Turku, Turku, Finland.
Foundation for the Finnish Cancer Institute , Helsinki, Finland.
InFLAMES Research Flagship Center, University of Turku and Åbo Akademi University, Turku, Finland.

Ilkka Paatero (I)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Benjamin T Goult (BT)

School of Biosciences, University of Kent, Canterbury, UK.
Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Guillaume Jacquemet (G)

Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
InFLAMES Research Flagship Center, University of Turku and Åbo Akademi University, Turku, Finland.
Turku Bioimaging, University of Turku and Åbo Akademi University, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH